Press releases
- Exact Sciences to Participate in June Investor Conferences
- Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
- Exact Sciences Earns 2024 Great Place To Work® Certification™
- Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
- Exact Sciences Announces First-Quarter 2024 Results
- Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
- Exact Sciences to Participate in May Investor Conference
- Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
- Exact Sciences Schedules First Quarter 2024 Earnings Call
- Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.73 |
---|---|
High | 39.73 |
Low | 39.73 |
Bid | 39.63 |
Offer | 40.11 |
Previous close | 39.96 |
Average volume | 290.71 |
---|---|
Shares outstanding | 184.53m |
Free float | 182.72m |
P/E (TTM) | -- |
Market cap | 8.41bn USD |
EPS (TTM) | -1.32 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 07:14 BST.
More ▼